LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Thromboprophylaxis in COVID-19 - Rationale and considerations.

Bristogiannis, Sotirios / Swan, Dawn / Thachil, Jecko

Advances in biological regulation

2021  Volume 81, Page(s) 100819

Abstract: ... of anticoagulation to mitigate this risk. In this review, we examine the rationale for thromboprophylaxis in COVID-19 ... The Corona Virus Disease-2019 (COVID-19) pandemic is associated with a very high incidence ... with particular reference to dosing and discuss what may guide the decision-making process to consider ...

Abstract The Corona Virus Disease-2019 (COVID-19) pandemic is associated with a very high incidence of thrombotic complications. The exact mechanisms for this excess risk for clots have not been elucidated although one of the often-quoted pathophysiological entity is immunothrombosis. Recognition of thrombotic complications early on in this pandemic led to an over-explosion of studies which looked at the benefits of anticoagulation to mitigate this risk. In this review, we examine the rationale for thromboprophylaxis in COVID-19 with particular reference to dosing and discuss what may guide the decision-making process to consider anticoagulation. In addition, we explore the rationale for thrombosis prevention measures in special populations including outpatient setting, pregnant females, children, those with high body mass index and those on extracorporeal membrane oxygenation.
MeSH term(s) Anticoagulants/therapeutic use ; COVID-19/complications ; COVID-19/epidemiology ; COVID-19/therapy ; Clinical Decision-Making ; Extracorporeal Membrane Oxygenation ; Humans ; SARS-CoV-2 ; Thrombosis/epidemiology ; Thrombosis/etiology ; Thrombosis/prevention & control
Chemical Substances Anticoagulants
Language English
Publishing date 2021-07-23
Publishing country England
Document type Journal Article ; Review
ZDB-ID 2667413-0
ISSN 2212-4934 ; 2212-4926
ISSN (online) 2212-4934
ISSN 2212-4926
DOI 10.1016/j.jbior.2021.100819
Shelf mark
Uc I Zs.364: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top